Advertisement

Topics

Boston Scientific acquires California─based women's healthcare company, nVision Medical for $275 million

09:57 EDT 17 Apr 2018 | PharmaBiz

Related Biotechnology, Pharmaceutical and Healthcare News

Boston Scientific, a global medical technology leader, has acquired nVision Medical Corporation, a privately─held company focused on women's health.

Original Article: Boston Scientific acquires California─based women's healthcare company, nVision Medical for $275 million

NEXT ARTICLE

More From BioPortfolio on "Boston Scientific acquires California─based women's healthcare company, nVision Medical for $275 million"

Advertisement

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
Advertisement

 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact BioPortfolio.
All rights reserved. All other trademarks recognized. Copyright © 1997-2018 BioPortfolio Limited. Site developed by Alacrify Ltd.